Transcatheter mitral valve repair with the PASCAL device showed high rates of survival and freedom from heart failure rehospitalization at 2 years in the single-arm, safety and efficacy CLASP study.
SAN FRANCISCO -- The Pascal device remained noninferior to MitraClip for prohibitive surgical risk patients with significant symptomatic degenerative mitral regurgitation (DMR) in full results from ...
LONDON, England—Two-year results from the CLASP IID randomized trial and registry confirm the early benefits of transcatheter edge-to-edge repair (TEER) with the Pascal system (Edwards Lifesciences) ...
KUALA LUMPUR: Institut Jantung Negara (IJN) has become the first hospital in Malaysia to clinically utilise the PASCAL Precision transcatheter valve repair system for patients with mitral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results